Samen Siz – Advancing Leukemia Detection with Cutting-Edge Technology
Samen Siz is an innovative biotech startup developing a next-generation leukemia detection system by integrating optics, artificial intelligence, and molecular diagnostics. Our mission is to revolutionize cancer diagnostics with a non-invasive, highly accurate, and cost-effective approach.
Our current focus is on advancing our optical MVP, which utilizes state-of-the-art imaging and AI-driven analysis to enhance cancer cell detection. Alongside this, we are continuously improving our cancer cell labeling method to further refine the accuracy and efficiency of leukemia diagnosis.
Samen Siz has been recognized globally, winning gold medals at innovation festivals in London, Switzerland and Thailand. With a patented approach and strong international collaborations, we are shaping the future of cancer diagnostics—bringing faster, safer, and more accessible solutions to patients and healthcare providers worldwide.
Armin Raji ( founder and CEO)
Milad Ghasemi ( COO)
